MOH said it will provide an update when it is ready, with a decision expected to be made in 2026. Read more at ...

Lebrikizumab improved disease severity, skin clearance and symptom relief in children with moderate to severe atopic ...

If you've seen a surge of videos about how to use a derma roller for hair growth on social media recently, you're not alone.

Lebrikizumab delivered significant skin clearance and improved disease severity in children with moderate-to-severe atopic ...

Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints: Indianapolis Tuesday, ...

Anyone with a chronic illness understands the struggle of living with a disease that is deeply unpredictable. Many such ...

Everyone’s favorite bracket challenge has returned. That’s right—it’s time once again for Fierce Pharma Marketing’s annual ...

The transition from winter to spring in Montana brings dramatic environmental shifts that contribute to the onset of specific dermatologic conditions. Fluctuations in temperature and humidity, alongsi ...

A string of FDA approvals and late-stage clinical trials has expanded the toolkit for treating seasonal and environmental allergies, giving patients new ways to manage symptoms and, in some cases, ...

Struggling with an oily T-zone and dry cheeks? Dermatologists explain combination skin — plus the tested products that help ...